Ledger.Open graph →
SEC Form D · Amendment · filed February 26, 2020

Neurana Pharmaceuticals, Inc

Offering
$64.9M
Sold
$41.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Brian F. Dorsey · San Diego, CADirectorCraig F. Thompson · San Diego, CAExec · DirectorDavid F. Kabakoff · San Diego, CADirectorRandall D. Kaye, M.D · San Diego, CAExecCraig F. Thompson · San Diego, CAExec · DirectorKathleen D. Scott · San Diego, CAExecJoshua F. Richardson · San Diego, CADirectorDavid F. Kabakoff · San Diego, CADirectorAlex F. Zisson · San Diego, CADirectorDavid F. Hale · Carlsbad, CADirectorDavid F. Hale · Del Mar, CADirectorKathleen D. Scott · San Diego, CAExecRandall D. Kaye, M.D · San Diego, CAExecJoshua F. Richardson · San Diego, CADirectorBrian F. Dorsey · San Diego, CADirectorAlex F. Zisson · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗